Kimberly-Clark (KMB) Morgan Stanley Global Consumer & Retail Conference summary
Event summary combining transcript, slides, and related documents.
Morgan Stanley Global Consumer & Retail Conference summary
12 Jan, 2026Organizational transformation and strategy
Migrating from a decentralized to a balanced matrixed organization to leverage scale in supply chain, innovation, marketing, and commercial execution, with foundational changes laid in 2024 and full implementation underway for 2025 and beyond.
New organizational model went live October 1, 2024, focusing on agile ways of working and global-to-local execution.
Emphasis on volume-plus-mix-led growth, supported by increased investment in innovation and productivity.
Supply chain transformation expected to deliver significant productivity savings and margin expansion.
Change management is a multi-year journey, with progress already visible.
Financial performance and growth outlook
Organic sales grew around 4% in the first nine months of 2024, with both volume and mix contributing positively.
Q3 organic sales growth impacted by transitory factors (restocking, storms, private label shipments) and some underlying demand softness in North America Professional and select international markets.
Category growth expected at the lower end of the 2%-3% range, with volume and mix as primary drivers; pricing not expected to be a major growth lever in a benign cost environment.
Participation, frequency, and trade-up remain key growth drivers, especially in adult incontinence and fem care globally.
Market share and brand investment
Global market share flat versus baseline in Q3, with gains or holds in about 50% of key country-category cohorts.
Notable share gains in China (Huggies), UK (Andrex, Kleenex), Australia (Huggies), and Brazil.
Increased focus on superior product offerings and brand investment, with a strategy to drive more consistent share gains internationally.
Latest events from Kimberly-Clark
- Transforming through innovation and acquisitions to build a global health and wellness leader.KMB
Barclays 18th Annual Americas Select Conference11 May 2026 - Q1 2026 delivered 2.7% sales growth and strong profit, with transformation and acquisitions progressing.KMB
Q1 2026 Prepared Remarks28 Apr 2026 - Q1 2026 delivered 2.7% sales growth and 2.1% adjusted EPS growth, with a strong 2026 outlook.KMB
Q1 2026 (Q&A)28 Apr 2026 - Innovation and acquisitions drive growth, margin expansion, and strong EPS outlook.KMB
Q4 2025 Prepared Remarks11 Apr 2026 - Board recommends director elections, auditor ratification, say-on-pay, and opposes independent chair proposal.KMB
Proxy filing23 Mar 2026 - Shareholders will vote on directors, executive pay, and auditor ratification at the annual meeting.KMB
Proxy filing23 Mar 2026 - Transformation, innovation, and Kenvue integration drive global growth and value creation.KMB
Consumer Analyst Group of New York Conference (CAGNY) 202619 Feb 2026 - Issuance of common stock for a merger was approved; final results to be filed with the SEC.KMB
AGM 20263 Feb 2026 - Q2 profit and EPS surged on organic growth, innovation, and raised full-year outlook.KMB
Q2 2024 Prepared Remarks3 Feb 2026 - Q2 organic sales up 5% and adjusted EPS up 19%-20%, with 2024 outlook raised.KMB
Q2 2024 (Q&A)3 Feb 2026